Inventor · disambiguated record
Kevin Kelnar
Also filed as: KELNAR KEVIN
20 granted patents·21 pending applications·423 citations·filing 2005–2016
96Inventor score
Top patents by PatentIndex Score
41 records- 0198US9506061B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Nov 29, 2016·165 cites·7 claims
- 0296US8173611B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2005·Granted May 8, 2012·27 cites·27 claims
- 0396US7960359B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2007·Granted Jun 14, 2011·37 cites·17 claims
- 0495US8058250B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Nov 15, 2011·20 cites·31 claims
- 0594US8586727B2Synthetic mimics of miR-34KELNAR KEVIN·Filed 2012·Granted Nov 19, 2013·22 cites·14 claims
- 0694US8563708B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2007·Granted Oct 22, 2013·15 cites·9 claims
- 0793US8258111B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisSHEN JIKUI·Filed 2009·Granted Sep 4, 2012·48 cites·16 claims
- 0892US8946177B2Methods and compositions involving miRNA and miRNA inhibitor moleculesBROWN DAVID·Filed 2011·Granted Feb 3, 2015·10 cites·16 claims
- 0990US8071562B2MiR-124 regulated genes and pathways as targets for therapeutic interventionBADER ANDREAS G·Filed 2008·Granted Dec 6, 2011·48 cites·11 claims
- 1086US9611478B2Synthetic mimics of miR-124MIRNA THERAPEUTICS INC·Filed 2015·Granted Apr 4, 2017·3 cites·24 claims
- 1185US9447414B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Sep 20, 2016·2 cites·3 claims
- 1285US9365852B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·2 cites·6 claims
- 1385US9051571B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 9, 2015·3 cites·28 claims
- 1485US8765709B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2013·Granted Jul 1, 2014·3 cites·22 claims
- 1584US9371526B2Synthetic mimics of miR-34MIRNA THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·3 cites·35 claims
- 1684US9222085B2Synthetic mimics of MIR-124KELNAR KEVIN·Filed 2012·Granted Dec 29, 2015·4 cites·20 claims
- 1783US9382537B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jul 5, 2016·2 cites·10 claims
- 1883US9068219B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 30, 2015·2 cites·33 claims
- 1982US8597892B2MiRNA biomarkers of prostate diseaseSHELTON JEFFREY·Filed 2010·Granted Dec 3, 2013·7 cites·9 claims
- 2067US2017037404A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2016·Application pending·0 cites
- 2167US2013303591A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 2266US2013143945A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 2364US9540645B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2016·Granted Jan 10, 2017·0 cites·6 claims
- 2464US2015361431A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2563US2015342981A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2663US2015284720A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2763US2015344883A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2863US2015299705A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2963US2011313025A1Methods and compositions involving mirna and mirna inhibitor moleculesBROWN DAVID·Filed 2011·Application pending·0 cites
- 3063US2015284719A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 3163US2015275213A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 3260US2014308274A1Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitorsMIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3358US2013065951A1Compositions and methods related to mirna modulation of neovascularization or angiogenesisSHEN JIKUI·Filed 2012·Application pending·0 cites
- 3455US2014235469A1Mirna biomarkers of prostate diseaseSHELTON JEFFREY·Filed 2013·Application pending·0 cites
- 3555US2009092974A1Micrornas differentially expressed in leukemia and uses thereofASURAGEN INC·Filed 2007·Application pending·0 cites
- 3655US2016053264A1Synthetic mimics of mir-34MIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3752US2017035797A1Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitorsMIRNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3851US2010179213A1Methods and Compositions Involving miRNAs In Cancer Stem CellsMIRNA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3951US2012282696A1Functions and targets of let-7 micro rnasJOHNSON CHARLES D·Filed 2012·Application pending·0 cites
- 4050US2014309278A1Combination cancer treatments utilizing micrornas and egfr-tki inhibitorsMIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4140US2015272981A1Combination cancer treatments utilizing micrornas and egfr-tki inhibitorsMIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →